Morphine for refractory breathlessness in COPD: a randomized clinical intervention study

C. Verberkt (Maastricht, Netherlands), M. Van Den Beuken-Van Everdingen (Maastricht, Netherlands), J. Schols (Maastricht, Netherlands), N. Hameleers (Maastricht, Netherlands), E. Wouters (Horn, Netherlands), D. Janssen (Horn, Netherlands)

Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Session: Clinical and basic pharmacology for COPD
Session type: E-poster session
Number: 177
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Verberkt (Maastricht, Netherlands), M. Van Den Beuken-Van Everdingen (Maastricht, Netherlands), J. Schols (Maastricht, Netherlands), N. Hameleers (Maastricht, Netherlands), E. Wouters (Horn, Netherlands), D. Janssen (Horn, Netherlands). Morphine for refractory breathlessness in COPD: a randomized clinical intervention study. 177

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of a breathlessness service for patients suffering from breathlessness in advanced disease: pragmatic fast-track randomized controlled trial
Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care
Year: 2020




Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation
Source: Eur Respir J 2014; 43: 717-724
Year: 2014



Tele-assistance in chronic respiratory failure patients: a randomised clinical trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008


Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial
Source: Eur Respir J, 52 (3) 1800887; 10.1183/13993003.00887-2018
Year: 2018



Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019
Year: 2020



Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018




Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
Source: Eur Respir J, 53 (1) 1801270; 10.1183/13993003.01270-2018
Year: 2019



Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018
Year: 2019



A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)
Source: ERJ Open Res, 7 (1) 00955-2020; 10.1183/23120541.00955-2020
Year: 2021



The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



A multi-centre, randomised controlled trial of positive expiratory pressure mask therapy for inpatients with acute exacerbations of COPD and sputum expectoration
Source: Annual Congress 2013 –Rehabilitation, exercise and adjunct physiotherapy techniques in different respiratory conditions
Year: 2013



Hypnosis for the management of COPD-related anxiety and dyspnoea in pulmonary rehabilitation: rationale and design for a cluster-randomised, active-control trial (HYPNOBPCO_2)
Source: ERJ Open Res, 8 (1) 00565-2021; 10.1183/23120541.00565-2021
Year: 2022



Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial
Source: Eur Respir J, 50 (4) 1701235; 10.1183/13993003.01235-2017
Year: 2017



ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016
Year: 2017



Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019



A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis
Source: Eur Respir J , 49 (3) 1602486; DOI: 10.1183/13993003.02486-2016
Year: 2017


The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


The role of phonophoresis in patients with COPD: a randomized clinical trial
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020